Cobra Biologics Awarded £2.6m ($3.4m USD) from Innovate UK

News   Jan 24, 2018 | Original story from Cobra Biologics

 
Cobra Biologics Awarded £2.6m ($3.4m USD) from Innovate UK

Peter Coleman, CEO Cobra Biologics

 
 
 

RELATED ARTICLES

Sheep Toxin Could Cause MS

News

Exposure to a toxin primarily found in sheep could be linked to the development of multiple sclerosis (MS) in humans, new research suggests.

READ MORE

Compound Offers Pain-relief of Opioids Without Addictive Properties

News

Researchers have engineered a new compound that animal tests suggest could offer the pain-relieving properties of opioids such as morphine and oxycodone without the risk of addiction.

READ MORE

E. Coli’s Internal Bomb Offers Chink In Armour

News

Bacteria's internal bomb, the so-called toxin-antitoxin (TA) system that is part of the normal bacterial makeup, may be triggered to make bacteria turn on themselves, providing a valuable target for novel antimicrobial approaches in drug design.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE